Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Gilbert

Showing results (241-250 of 247) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 247 results.
Journal of Neuro-Oncology|October 9, 2017
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02Phioanh Leia Nghiemphu, Victoria Asuquo Ebiana, Patrick Wen, et al.
Plos One|August 23, 2017
A syndemic approach to assess the effect of substance use and social disparities on the evolution of HIV/HCV infections in British ColumbiaZahid Ahmad Butt, Nabin Shrestha, Stanley Wong, et al.
Biorxiv : the Preprint Server for Biology|June 29, 2026
Systemic viral vector vaccination induces brain resident memory T cells to drive anti-glioblastoma immunityEmily E Steffke, Laila Latifi, Taijun Hana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, et al.
Nature Genetics|July 31, 2007
C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophyAnna Richards, Arn M J M van den Maagdenberg, Joanna C Jen, et al.
Cancer Cell|May 13, 2015
Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age GroupsKristian W Pajtler, Hendrik Witt, Martin Sill, et al.
Neuro-Oncology Advances|July 30, 2025
Molecular, histologic, and clinical characterization of methylation class pleomorphic xanthoastrocytoma: An analysis of 469 tumorsChristopher H Dampier, Niharika Shah, Kristyn Galbraith, et al.
Pageof 25

Showing results (241-250 of 247) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 247 results.
Journal of Neuro-Oncology|October 9, 2017
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02Phioanh Leia Nghiemphu, Victoria Asuquo Ebiana, Patrick Wen, et al.
Plos One|August 23, 2017
A syndemic approach to assess the effect of substance use and social disparities on the evolution of HIV/HCV infections in British ColumbiaZahid Ahmad Butt, Nabin Shrestha, Stanley Wong, et al.
Biorxiv : the Preprint Server for Biology|June 29, 2026
Systemic viral vector vaccination induces brain resident memory T cells to drive anti-glioblastoma immunityEmily E Steffke, Laila Latifi, Taijun Hana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, et al.
Nature Genetics|July 31, 2007
C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophyAnna Richards, Arn M J M van den Maagdenberg, Joanna C Jen, et al.
Cancer Cell|May 13, 2015
Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age GroupsKristian W Pajtler, Hendrik Witt, Martin Sill, et al.
Neuro-Oncology Advances|July 30, 2025
Molecular, histologic, and clinical characterization of methylation class pleomorphic xanthoastrocytoma: An analysis of 469 tumorsChristopher H Dampier, Niharika Shah, Kristyn Galbraith, et al.
Pageof 25